Yang, Xu
Lian, Baofeng
Zhang, Nan
Long, Junyu
Li, Yiran
Xue, Jingnan
Chen, Xiangqi
Wang, Yunchao
Wang, Yanyu
Xun, Ziyu
Piao, Mingjian
Zhu, Chenpei
Wang, Shanshan
Sun, Huishan
Song, Zhijian
Lu, Leilei
Dong, Xiaowei
Wang, Aodi
Liu, Wenjin
Pan, Jie
Hou, Xiaorong
Guan, Mei
Huo, Li
Shi, Jie
Zhang, Haohai
Zhou, Jinxue
Lu, Zhenhui
Mao, Yilei
Sang, Xinting
Wu, Liqun
Yang, Xiaobo
Wang, Kai
Zhao, Haitao http://orcid.org/0000-0002-3444-8044
Funding for this research was provided by:
National High Level Hospital Clinical Research Funding (2022-PUMCH-B-128)
CAMS Innovation Fund for Medical Sciences (2022-I2M-C&T-A-003, 2021-I2M-1-061, 2021-I2M-1-003)
CAMS Clinical and Translational Medicine Research Funds (2019XK320006)
CSCO-hengrui Cancer Research Fund (Y-HR2019-0239, Y-HR2020MS-0415, Y-HR2020QN-0414)
CSCO-MSD Cancer Research Fund (Y-MSDZD2021-0213)
National Ten-thousand Talent Program
the Fundamental Research Funds for the Central Universities (3332023011)
the Young Scientists Fund of the National Natural Science Foundation of China (82303720)
Article History
Received: 21 July 2023
Accepted: 15 January 2024
First Online: 29 January 2024
Declarations
:
: The study protocol (JS-1391) was approved by the Institutional Ethics Review Committee at PUMCH and QDUH (NCT03892577; RWSHBC). The study obtained written informed consent from all participants and was approved by the Institutional Ethics Review Committee at PUMCH and QDUH (NCT03892577; RWSHBC).
: Not applicable.
: Kai Wang is an employer of OrigiMed Co., Ltd. Kai Wang, Leilei Lu, Zhijian Song and Baofeng Lian, Xiaowei Dong, Aodi Wang, and Wenjin Liu are employees of OrigiMed Co., Ltd. The other authors report no potential conflicts of interest for this work.